Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
äŒæ¥ã³ãŒãINBS
äŒç€ŸåIntelligent Bio Solutions Inc
äžå Žæ¥Dec 23, 2020
æé«çµå¶è²¬ä»»è
ãCEOãSimeonidis (Harry)
åŸæ¥å¡æ°16
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Dec 23
æ¬ç€Ÿæåšå°135 W 41St St,
éœåžNEW YORK
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·10036
é»è©±çªå·16467905756
ãŠã§ããµã€ãhttps://ibs.inc/
äŒæ¥ã³ãŒãINBS
äžå Žæ¥Dec 23, 2020
æé«çµå¶è²¬ä»»è
ãCEOãSimeonidis (Harry)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã